The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
Authors:
- 3 October 2022
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 65, 100882
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanismsCell, 2021
- Emergence of a Novel SARS-CoV-2 Variant in Southern CaliforniaJAMA, 2021
- Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016Cell Reports Medicine, 2021
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesCell, 2021
- Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Nature, 2021
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Science, 2021
- In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD InterfaceInternational Journal of Molecular Sciences, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostNew England Journal of Medicine, 2020
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020medRxiv, 2020